Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PRESTIGE CONSUMER HEALTHCARE INC.

(PBH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
55.92(c) 55.95(c) 57.11(c) 57.59(c) 57.75(c) Last
202 731 290 765 225 541 189 024 172 580 Volume
-0.87% +0.05% +2.07% +0.84% +0.28% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 1 060 M - -
Net income 2022 197 M - -
Net Debt 2022 - - -
P/E ratio 2022 14,9x
Yield 2022 -
Sales 2023 1 096 M - -
Net income 2023 217 M - -
Net Debt 2023 - - -
P/E ratio 2023 13,5x
Yield 2023 -
Capitalization 2 894 M 2 894 M -
Capi. / Sales 2022 2,73x
Capi. / Sales 2023 2,64x
Nbr of Employees 505
Free-Float 91,6%
More Financials
Company
Prestige Consumer Healthcare Inc. is engaged in the marketing, sales and distribution of over the counter (OTC) healthcare products to mass merchandisers, drug, food, dollar, convenience and club stores and e-commerce channels in North America (the United States and Canada), and in Australia and certain other international markets. The Company operates through two segments: North American OTC Healthcare and... 
Sector
Pharmaceuticals
Calendar
02/03Earnings Release
More about the company
Ratings of Prestige Consumer Healthcare Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D+
More Ratings
All news about PRESTIGE CONSUMER HEALTHCARE INC.
12/02PRESTIGE CONSUMER HEALTHCARE : Morgan Stanley Virtual Global Consumer & Retail Conference
PU
11/15INSIDER SELL : Prestige Consumer Healthcare
MT
11/15DA Davidson Adjusts Price Target on Prestige Consumer Healthcare to $63 from $61, Keeps..
MT
11/04Q2 2022 Prestige Consumer Healthcare Inc. Earnings Conference Call
PU
11/04Prestige Consumer Healthcare Fiscal Q2 Adjusted Earnings, Revenue Rise; Fiscal 2022 Gui..
MT
11/04PRESTIGE BRANDS : Fiscal Q2 Earnings Snapshot
AQ
11/04PRESTIGE CONSUMER HEALTHCARE INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CO..
AQ
11/04Prestige Consumer Healthcare Inc. Reports Earnings Results for the Second Quarter and S..
CI
11/04Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Second Quarter Results - Form 8-K
PU
11/04PRESTIGE CONSUMER HEALTHCARE INC. : Results of Operations and Financial Condition, Regulat..
AQ
11/04Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE Posts Q2 EPS $1.02
MT
11/04Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE Reports Q2 Revenue $276.2M
MT
11/04Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Second Quarter Results
AQ
11/04Prestige Consumer Healthcare Inc. Revises Earnings Guidance for the Full Year 2022
CI
10/06PRESTIGE CONSUMER HEALTHCARE : Inc. to Release Fiscal 2022 Second Quarter Earnings Results
GL
More news
News in other languages on PRESTIGE CONSUMER HEALTHCARE INC.
11/15VENTE D'INITIÉS : Prestige Consumer Healthcare
11/04Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE annonce un chiffre d'affaires de 276,..
11/04Prestige Consumer Healthcare Inc. révise ses prévisions de bénéfices pour l'ensemble de..
08/05Prestige Consumer Healthcare affiche un bénéfice et un chiffre d'affaires plus élevés a..
08/05Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE affiche un chiffre d'affaires de 269,..
More news
Analyst Recommendations on PRESTIGE CONSUMER HEALTHCARE INC.
More recommendations
Chart PRESTIGE CONSUMER HEALTHCARE INC.
Duration : Period :
Prestige Consumer Healthcare Inc. Technical Analysis Chart | PBH | US74112D1019 | MarketScreener
Technical analysis trends PRESTIGE CONSUMER HEALTHCARE INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 57,75 $
Average target price 68,00 $
Spread / Average Target 17,7%
EPS Revisions
Managers and Directors
Ronald M. Lombardi Chairman, President & Chief Executive Officer
Christine Sacco Chief Financial Officer
Jeff Zerillo Senior Vice President-Operations
John E. Byom Independent Director
Sheila A. Hopkins Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PRESTIGE CONSUMER HEALTHCARE INC.63.78%2 894
JOHNSON & JOHNSON1.27%419 583
ROCHE HOLDING AG17.62%341 364
PFIZER, INC.44.09%304 610
NOVO NORDISK A/S64.51%244 010
ELI LILLY AND COMPANY47.55%222 641